DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

DexCom, Inc.

Dexcom develops and manufactures continuous glucose monitoring (CGM) systems for diabetes management.

Dexcom

Dexcom Corporation is a pioneer and global leader in continuous glucose monitoring (CGM).  Dexcom began as a small company with a big dream: To forever change how diabetes is managed. To unlock information and insights that drive better health outcomes. Here we are 25 years later, having pioneered an industry. And we're just getting started.  We are broadening our vision beyond diabetes to empower people to take control of health. That means personalized, actionable insights aimed at solving important health challenges. To continue what we've started: Improving human health. We are driven by over 10,000 ambitious, passionate people worldwide who are willing to fight like warriors to earn the trust of our customers by listening, serving with integrity, thinking big, and being dependable. We've already changed millions of lives and we're ready to change millions more.  Our future ambition is to become a leading consumer health technology company while continuing to develop solutions for serious health conditions. We'll get there by constantly reinventing unique biosensing-technology experiences. Though we've come a long way from our small company days, our dreams are bigger than ever. The opportunity to improve health on a global scale stands before us.

msh id	COM:DEXCOM
symbol	DXCM
name	DexCom, Inc.
homepage url	https://www.dexcom.com
country	US
sector	Healthcare
industry	Medical - Devices
market	STOCKS
employee count	9.5K
crunchbase url	-
linkedin url	-
founders	-

market cap	44.06B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.2
growth cost of revenue	0.3
growth depreciation and amortization	6.24
growth ebitda	1.2
growth ebitda ratio	0.77
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	0.22
growth gross profit ratio	-0.02

COM:DEXCOM

Dexcom

Last Close

75.24

21/11 20:59

Market Cap

44.06B

Beta: -

Volume Today

3.13M

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	3.02B
cost of revenue	3.02B
depreciation and amortization	186M
ebitda	916.7M
ebitda ratio	0.25
eps	1.4
eps diluted	1.3
operating expenses	1.69B
operating income	597.7M
operating income ratio	0.17

accounts receivables	-260.1M
capital expenditure	-236.6M
cash at beginning of period	643.3M
cash at end of period	567.5M
inventory	559.6M
working capital ttm	3.02B

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-